NeuPath Health Inc. filed its Annual on Mar 30, 2023 for the period ending Dec 31, 2022. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2 CAD | -11.11% | +2.56% | +8.11% |
16/05 | NeuPath Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
15/03 | NeuPath Health Narrows Q4 Loss, Revenue Rises | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.11% | 8.18M | |
+26.08% | 89.38B | |
-23.66% | 75.67B | |
+6.34% | 28.83B | |
+5.34% | 18.25B | |
-13.80% | 16.51B | |
+2.60% | 15.72B | |
+78.26% | 13.71B | |
+82.29% | 13.46B | |
+23.94% | 12.64B |
- Stock Market
- Equities
- NPTH Stock
- News NeuPath Health Inc.
- NeuPath Health Inc. Auditor Raises 'Going Concern' Doubt